3SBio (1530 HK)

196

Analysis

Health Care • China

3SBio is a leading biotechnology company engaged in the research, development, manufacturing, and marketing of biopharmaceutical products. The company's diverse portfolio addresses therapeutic areas such as nephrology, oncology, supportive cancer care, inflammation, infectious diseases, autoimmune diseases, metabolism, and dermatology, with key products including EPIAO and TPIAO. 3SBio was founded in 1993 and is headquartered in Shenyang, China.

Refresh

Exchange Announcement • 14 Oct 2026 17:42

Next Day Disclosure Return

Exchange Announcement • 13 Oct 2026 17:54

Next Day Disclosure Return

Exchange Announcement • 12 Oct 2026 18:09

Next Day Disclosure Return

Exchange Announcement • 09 Oct 2026 18:38

Next Day Disclosure Return

Exchange Announcement • 08 Oct 2026 18:17

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00